HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hudspeth, D. A. Articles by Hammon, J. W. Search for Related Content PubMed PubMed Citation Articles by Hudspeth, D. A. Articles by Hammon, J. W., Jr

The Annals of Thoracic Surgery, Vol 58, 1637-1644, Copyright © 1994 by The Society of Thoracic Surgeons

ARTICLES

Adenosine in blood cardioplegia prevents postischemic dysfunction in ischemically injured hearts

DA Hudspeth, K Nakanishi, J Vinten-Johansen, ZQ Zhao, DS McGee, MW Williams and JW Hammon Jr
Department of Cardiothoracic Surgery, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27157-1096.

Adenosine (ADO) is an endogenous cardioprotective autacoid that exerts receptor-mediated cardioprotection from ischemic-reperfusion injury. This study tested the hypothesis that blood cardioplegia (BCP) supplemented with ADO reduces postischemic left ventricular dysfunction in ischemically injured hearts. Twenty-one anesthetized dogs on total bypass were subjected to 30 minutes of normothermic global ischemia. Cold (4 degrees C) potassium BCP was then delivered every 20 minutes for 60 minutes of cardioplegic arrest. In 7 dogs, unsupplemented BCP was used; in 7 dogs, BCP was supplemented with 400 mumol/L ADO; and, in 7 dogs, ADO receptors were blocked with 8-p-sulfophenyltheophylline (30 mg/kg) given with 400 mumol/L ADO in BCP. Preischemic and postischemic left ventricular systolic function was assessed by the slope and volume axis intercept of the end-systolic pressure-volume (impedance catheter) relationship (ESPVR). In unsupplemented BCP, the postischemic slope of the ESPVR was significantly depressed by 42% versus the preischemic value (from 6.8 +/- 1.2 mm Hg/mL to 3.9 +/- 0.4 mm Hg/mL; p < 0.05 versus the preischemic value). In contrast, BCP supplemented with ADO was found to restore the postischemic ESPVR slope to preischemic levels (7.7 +/- 1.0 mm Hg/mL versus 7.4 +/- 1.2 mm Hg/mL, respectively). This cardioprotection was reversed by 8-p-sulfophenyltheophylline (9.9 +/- 1.5 mm Hg/mL versus 4.5 +/- 0.7 mm Hg/mL; p < 0.05 versus the preischemic value). Postischemic plasma creatinine kinase activity was elevated equally in all groups over the baseline values. We conclude that ADO in BCP attenuates postcardioplegia dysfunction in severely injured hearts through the operation of receptor-mediated mechanisms.

This article has been cited by other articles:

				J. Martin, G. Lutter, C. Ihling, M. Siepe, S. Wagner, J. Hilberath, M. Kemper, K. Sarai, and F. Beyersdorf Myocardial viability twenty-four hours after orthotopic heart transplantation from non-heart-beating donors J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1217 - 1228. [Abstract] [Full Text] [PDF]

				J. Vinten-Johansen, Z.-Q. Zhao, J. S. Corvera, C. D. Morris, J. M. Budde, V. H. Thourani, and R. A. Guyton Adenosine in myocardial protection in on-pump and off-pump cardiac surgery Ann. Thorac. Surg., February 1, 2003; 75(2): S691 - 699. [Abstract] [Full Text] [PDF]

				B. G. Fogelson, S. I. Nawas, and W. R. Law MECHANISMS OF MYOCARDIAL PROTECTION BY ADENOSINE-SUPPLEMENTED CARDIOPLEGIC SOLUTION: MYOFILAMENT AND METABOLIC RESPONSES J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 601 - 609. [Abstract] [Full Text] [PDF]

				V. H. Thourani, R. S. Ronson, D. G.L. Van Wylen, S. T. Shearer, S. L. Katzmark, Z.-Q. Zhao, D. C. Han, R. A. Guyton, and J. Vinten-Johansen Adenosine-Supplemented Blood Cardioplegia Attenuates Postischemic Dysfunction After Severe Regional Ischemia Circulation, November 9, 1999; 100(90002): II-376 - 383. [Abstract] [Full Text] [PDF]

				J. Vinten-Johansen, V. H. Thourani, R. S. Ronson, J. E. Jordan, Z.-Q. Zhao, M. Nakamura, D. Velez, and R. A. Guyton Broad-spectrum cardioprotection with adenosine Ann. Thorac. Surg., November 1, 1999; 68(5): 1942 - 1948. [Abstract] [Full Text] [PDF]

				V. H. Thourani, R. S. Ronson, J. E. Jordan, R. A. Guyton, and J. Vinten-Johansen Adenosine A3 pretreatment before cardioplegic arrest attenuates postischemic cardiac dysfunction Ann. Thorac. Surg., June 1, 1999; 67(6): 1732 - 1737. [Abstract] [Full Text] [PDF]

				A. M. Jayawant and R. J. Damiano Jr The superiority of pinacidil over adenosine cardioplegia in blood-perfused isolated hearts Ann. Thorac. Surg., October 1, 1998; 66(4): 1329 - 1335. [Abstract] [Full Text] [PDF]

				J. Vinten-Johansen Invited commentary Ann. Thorac. Surg., October 1, 1998; 66(4): 1335 - 1336. [Full Text] [PDF]

				A. Jovanovic, J. R. Lopez, A. E. Alekseev, W. K. Shen, and A. Terzic Adenosine Prevents K-Induced Ca2 Loading: Insight Into Cardioprotection During Cardioplegia Ann. Thorac. Surg., February 1, 1998; 65(2): 586 - 586. [Abstract] [Full Text] [PDF]

				T. O. Cheng, A. Jovanovic, J. R. Lopez, A. E. Alekseev, W. K. Shen, and A. Terzic Adenosine and K+-Induced Ca2+ Loading Ann. Thorac. Surg., August 1, 1997; 64(2): 588 - 589. [Full Text]

				M. H. Cox, S.-J. O, L. Hebbar, R. Mukherjee, F. A. Crawford Jr, and F. G. Spinale Protective Effects of Adenosine on Myocyte Contractility During Cardioplegic Arrest Ann. Thorac. Surg., April 1, 1997; 63(4): 981 - 987. [Abstract] [Full Text]

				J. Todd, Z.-Q. Zhao, M. W. Williams, H. Sato, D. G. L. Van Wylen, and J. Vinten-Johansen Intravascular Adenosine at Reperfusion Reduces Infarct Size and Neutrophil Adherence Ann. Thorac. Surg., November 1, 1996; 62(5): 1364 - 1372. [Abstract] [Full Text]

				J. Vinten-Johansen and J. W. Hammon Jr. Cardioprotection by adenosine: Is it a question of effective dose, timing, or the target compartment? J. Thorac. Cardiovasc. Surg., July 1, 1996; 112(1): 202 - 203. [Full Text]

				I. B. Krukenkamp and S. Levitsky Myocardial Protection: Modern Studies Ann. Thorac. Surg., May 1, 1996; 61(5): 1581 - 1582. [Full Text]

				R. D. Lasley and R. M. Mentzer Jr Protective Effects of Adenosine in the Reversibly Injured Heart Ann. Thorac. Surg., September 1, 1995; 60(3): 843 - 846. [Abstract] [Full Text]

				J. Vinten-Johansen, Z.-Q. Zhao, and H. Sato Reduction in Surgical Ischemic-Reperfusion Injury With Adenosine and Nitric Oxide Therapy Ann. Thorac. Surg., September 1, 1995; 60(3): 852 - 857. [Abstract] [Full Text]